Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protein-based immune profiles of basal-like vs. luminal breast cancers.
Walens A, Olsson LT, Gao X, Hamilton AM, Kirk EL, Cohen SM, Midkiff BR, Xia Y, Sherman ME, Nikolaishvili-Feinberg N, Serody JS, Hoadley KA, Troester MA, Calhoun BC. Walens A, et al. Among authors: calhoun bc. Lab Invest. 2021 Jun;101(6):785-793. doi: 10.1038/s41374-020-00506-0. Epub 2021 Feb 23. Lab Invest. 2021. PMID: 33623115 Free PMC article.
Borderline Estrogen Receptor-Positive Breast Cancers in Black and White Women.
Benefield HC, Allott EH, Reeder-Hayes KE, Perou CM, Carey LA, Geradts J, Sun X, Calhoun BC, Troester MA. Benefield HC, et al. Among authors: calhoun bc. J Natl Cancer Inst. 2020 Jul 1;112(7):728-736. doi: 10.1093/jnci/djz206. J Natl Cancer Inst. 2020. PMID: 31742342 Free PMC article.
Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features.
Benefield HC, Reeder-Hayes KE, Nichols HB, Calhoun BC, Love MI, Kirk EL, Geradts J, Hoadley KA, Cole SR, Earp HS, Olshan AF, Carey LA, Perou CM, Troester MA. Benefield HC, et al. Among authors: calhoun bc. JNCI Cancer Spectr. 2020 Sep 23;5(1):pkaa072. doi: 10.1093/jncics/pkaa072. eCollection 2021 Feb. JNCI Cancer Spectr. 2020. PMID: 33442657 Free PMC article. Clinical Trial.
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.
Anders CK, Woodcock MG, Van Swearingen AED, Moore DT, Sambade MJ, Laurie S, Robeson A, Kolupaev O, Cuaboy LA, Garrett AL, McKinnon K, Cowens K, Bortone D, Calhoun BC, Wilkinson AD, Carey L, Jolly T, Muss H, Reeder-Hayes K, Kaltman R, Jankowitz R, Gudena V, Olajide O, Perou C, Dees EC, Vincent BG, Serody JS. Anders CK, et al. Among authors: calhoun bc. J Immunother Cancer. 2022 Feb;10(2):e003427. doi: 10.1136/jitc-2021-003427. J Immunother Cancer. 2022. PMID: 35121644 Free PMC article. Clinical Trial.
The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.
Hamilton AM, Hurson AN, Olsson LT, Walens A, Nsonwu-Farley J, Kirk EL, Abdou Y, Downs-Canner SM, Serody JS, Perou CM, Calhoun BC, Troester MA, Hoadley KA. Hamilton AM, et al. Among authors: calhoun bc. Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1341-1350. doi: 10.1158/1055-9965.EPI-21-1312. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35437570 Free PMC article.
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.
Hurson AN, Hamilton AM, Olsson LT, Kirk EL, Sherman ME, Calhoun BC, Geradts J, Troester MA. Hurson AN, et al. Among authors: calhoun bc. Breast Cancer Res Treat. 2023 May;199(1):147-154. doi: 10.1007/s10549-023-06888-1. Epub 2023 Mar 9. Breast Cancer Res Treat. 2023. PMID: 36892725 Free PMC article.
158 results